S.D. Admin. R. 20:51:31:01

Current through Register Vol. 50, page 162, June 24, 2024

Section 20:51:31:01 - Definitions

Terms used in this chapter mean:

(1) "Compounding," the constitution, reconstitution, combination, dilution, or another process causing a change in the form, composition, or strength of any ingredient or any other attribute of a product;

(2) "Hazardous drug," a pharmaceutical that is antineoplastic, carcinogenic, mutagenic, or teratogenic;

(3) "Nonsterile compounding," the process of combining, admixing, diluting, pooling, reconstituting other than as provided in the manufacturer's labeling, or otherwise altering a drug or bulk drug substance to create a non-sterile preparation; and

(4) "Sterile compounding," the aseptic processing of any pharmaceutical preparation that is required to be sterile when administered to patients.

S.D. Admin. R. 20:51:31:01

36 SDR 100, effective 12/14/2009; 50 SDR 138, effective 6/2/2024

General Authority: SDCL 36-11-11(1)(3).

Law Implemented: SDCL 36-11-2.2(3).